This webinar looks at presentations of diabetes and the effects of COVID-19. Novo Nordisk has fully funded all costs for the development of this webinar. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of the RCGP. COVID-19 & Diabetes
An educational grant was received by Novo Nordisk for the production of this hub. Editorial and content decisions were made solely by the RCGP.
Last modified: Monday, 10 May 2021, 3:15 PM